[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - November 2006

  ANDA Number Generic Drug Name Applicant Approval Date
1 40-721 BETHANECHOL CHLORIDE TABLETS USP, 50 MG   IMPAX LABORATORIES, INC. 11/1/2006 
2 40-739 BETHANECHOL CHLORIDE TABLETS USP, 5 MG   IMPAX LABORATORIES, INC. 11/1/2006 
3 40-740 BETHANECHOL CHLORIDE TABLETS USP, 25 MG   IMPAX LABORATORIES, INC. 11/1/2006 
4 40-741 BETHANECHOL CHLORIDE TABLETS USP, 10 MG   IMPAX LABORATORIES, INC. 11/1/2006 
5 77-723 HYDROCODONE BITARTRATE AND IBUPROFEN TABLETS, 7.5 MG/200 MG AND 10 MG/200 MG   VINTAGE PHARMACEUTICALS, LLC 11/6/2006 
6 77-727 HYDROCODONE BITARTRATE AND IBUPROFEN TABLETS, 5 MG/200 MG   VINTAGE PHARMACEUTICALS, LLC 11/6/2006 
7 65-377 DOXYCYCLINE TABLETS, 50 MG, 75 MG, AND 100 MG   MYLAN PHARMACEUTICALS, INC. 11/7/2006 
8 78-102 MELOXICAM TABLETS, 7.5 MG AND 15 MG   TARO PHARMACEUTICAL INDUSTRIES, LTD. 11/7/2006 
9 40-593 PROMETHAZINE HYDROCHLORIDE INJECTION USP, 25 MG/ML AND 50 MG/ML; 1 ML AMPULES   SANDOZ CANADA, INC. 11/8/2006 
10 76-644 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, 10 MG   MYLAN PHARMACEUTICALS, INC. 11/9/2006 
11 76-702 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, 5 MG   MYLAN PHARMACEUTICALS INC. 11/9/2006 
12 76-745 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, 15 MG   IMPAX LABORATORIES, INC. 11/9/2006 
13 77-698 THALLOUS CHLORIDE Tl-201 INJECTION USP, 2 mCi/mL   TCI MEDICAL, INC. 11/9/2006 
14 77-612 SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION USP, 200 MG/40 MG PER 5 ML   TEVA PHARMACEUTICALS USA 11/13/2006 
15 77-015 SULFACETAMIDE SODIUM TOPICAL SUSPENSION USP, 10%   ALTANA INC. 11/17/2006 
16 77-730 PRAVASTATIN SODIUM TABLETS, 10 MG, 20 MG, 30 MG, AND 40 MG   PLIVA HRVATSKA d.o.o. 11/21/2006 
17 76-759 ONDANSETRON INJECTION USP, 2 MG/ML (PRESERVATIVE-FREE); 2ML VIALS   TEVA PHARMACEUTICALS USA 11/22/2006 
18 76-876 ONDANSETRON INJECTION USP, 2 MG/ML; 40 ML VIALS   TEVA PHARMACEUTICALS USA 11/22/2006 
19 77-480 ONDANSETRON AND DEXTROSE INJECTION, 0.64 MG/ML, 50 ML FLEXIBLE PLASTIC CONTAINERS   SICOR PHARMACEUTICALS, INC. 11/22/2006 
20 65-314 AMPICILLIN AND SULBACTAM FOR INJECTION USP, 10 GRAMS (BASE)/5 GRAMS (BASE) 15 GM PHARMACY BULK PACKAGE   INSTITUTO BIOCHIMICO ITALIANO, S.P.A. 11/27/2006 
21 65-353 DOXYCYCLINE TABLETS, 50 MG, 75 MG, AND 100 MG   SANDOZ INC. 11/27/2006 
22 77-574 PACLITAXEL INJECTION USP, 6 MG/ML; 5 ML, 16.7 ML, AND 50 ML VIALS   DABUR ONCOLOGY PLC 11/27/2006 
23 65-141 CEFAZOLIN FOR INJECTION USP, (PHARMACY BULK PACKAGE) 100 G AND 300 G   SAMSON MEDICAL TECHNOLOGIES, L.L.C. 11/29/2006 
24 77-289 CITALOPRAM HYDROBROMIDE TABLETS, 10 MG (BASE), 20 MG (BASE) AND 40 MG (BASE)   INTERPHARM INC. 11/30/2006 
25 77-536 MOEXIPRIL HYDROCHLORIDE TABLETS, 7.5 MG AND 15 MG   PADDOCK LABORATORIES, INC. 11/30/2006 

Back to Top      Back to Approvals

Date created: December 7, 2006

horizonal rule